The life science market is poised for significant growth — 10.28% annually from 2026 to 2034, with the global market reaching $269 billion by 2034 — driven by AI innovation, precision medicine, and sustainable practices, against headwinds of regulatory uncertainty, funding fluctuations, and changing demand. This ETS deck is the complete version of our 2026 life science analysis.
The market section covers the leading players, real estate, funding, and regulatory pressures, the three trends shaping the future (digital transformation and AI, innovation and regulation, corporate strategy), North America's leadership and the emerging biotech hubs of China and India, and a workforce and investment landscape that rewards differentiated capabilities.
The solutions section goes deep on how SAP supports the industry: real-time analytics, predictive analytics, and end-to-end visibility for supply chain resilience; document management, audit trails, quality management with CAPA, and automated regulatory reporting for FDA and EMA compliance; advanced demand planning, S&OP, inventory optimization, and scenario planning for demand variability; supplier collaboration, risk tools, and alternative sourcing for raw material shortages; batch and lot tracking and flexible manufacturing; IoT data integration, automated decision-making, smart logistics, and sustainability monitoring; SuccessFactors for the talent shortage; and a seven-part cybersecurity model.
The full deck is available above as a PDF. Shorter formats are also in the Resource Library: the "2026 Life Science Market Fact Sheet" and the "2026 Life Science Market Overview: Executive Brief".